once weekly semaglutide in adults with alcohol use disorder While only three medications have been FDA-approved for the last 75 years, #semaglutide is emerging as a potent new candidate for helping patients cut back on drinking. John Semaglutide and Tirzepatide reduce alcohol

Therefore, the effective therapy of many neurodegenerative disorders of the central nervous system (CNS) such as Parkinsons disease (PD) or Alzheimers disease (AD) remains a serious challenge

Do not stop semaglutide, increase your dose or switch medications without medical guidance

Solids almost certainly pose more of an aspiration risk than liquids

Adipose Mesenchymal Stem Cells: A Breakthrough in Minimally Invasive Joint Repair By Bob Berendsen February 5, 2025 Regenerative medicine is transforming orthopedic care, and Adipose-Derived Mesenchymal Stem Cells (AMSCs) are at the forefront of this innovation

Bergh, E

Clinical Assessment: Additional testing may be recommended where appropriate